Terms: = Endocrine gland cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Diagnosis
20 results:
1. Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing.
Yao X; Zhou H; Duan C; Wu X; Li B; Liu H; Zhang Y
Front Immunol; 2022; 13():1096494. PubMed ID: 36713456
[TBL] [Abstract] [Full Text] [Related]
2. The value of sox2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
[TBL] [Abstract] [Full Text] [Related]
3. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract] [Full Text] [Related]
4. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
[TBL] [Abstract] [Full Text] [Related]
5. Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma.
Davidson B; Holth A; Dong HP
Virchows Arch; 2020 Nov; 477(5):677-685. PubMed ID: 32472195
[TBL] [Abstract] [Full Text] [Related]
6. Effects of Fentanyl on pancreatic cancer cell proliferation and cancer stem cell differentiation.
Celik F; Duran T
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):21-25. PubMed ID: 31880513
[TBL] [Abstract] [Full Text] [Related]
7. SOX 2 Expression in Human Pituitary Adenomas-Correlations With Pituitary Function.
Capatina C; Cimpean AM; Raica M; Coculescu M; Poiana C
In Vivo; 2019; 33(1):79-83. PubMed ID: 30587606
[TBL] [Abstract] [Full Text] [Related]
8. Expression of microRNA-145, OCT4, and sox2 in double primary endometrioid endometrial and ovarian carcinomas.
Zhang R; Jiao J; Chu H; Yang H; Wang L; Gao N
Histol Histopathol; 2018 Aug; 33(8):859-870. PubMed ID: 29569698
[TBL] [Abstract] [Full Text] [Related]
9. Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urological Pathology consensus conference.
Ulbright TM; Tickoo SK; Berney DM; Srigley JR;
Am J Surg Pathol; 2014 Aug; 38(8):e50-9. PubMed ID: 24832161
[TBL] [Abstract] [Full Text] [Related]
10. Testicular cancer: biology and biomarkers.
Looijenga LH; Stoop H; Biermann K
Virchows Arch; 2014 Mar; 464(3):301-13. PubMed ID: 24487784
[TBL] [Abstract] [Full Text] [Related]
11. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.
Rabban JT; Zaloudek CJ
Histopathology; 2013 Jan; 62(1):71-88. PubMed ID: 23240671
[TBL] [Abstract] [Full Text] [Related]
12. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
[TBL] [Abstract] [Full Text] [Related]
13. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract] [Full Text] [Related]
14. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Emerson RE; Ulbright TM
Pathology; 2010 Jun; 42(4):344-55. PubMed ID: 20438407
[TBL] [Abstract] [Full Text] [Related]
15. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract] [Full Text] [Related]
16. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, sox2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
[TBL] [Abstract] [Full Text] [Related]
17. [Advances in basic research on testicular germ cell tumors : clinical implications].
Looijenga LH
Urologe A; 2009 Apr; 48(4):350-8. PubMed ID: 19352605
[TBL] [Abstract] [Full Text] [Related]
18. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract] [Full Text] [Related]
19. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
[TBL] [Abstract] [Full Text] [Related]
20. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract] [Full Text] [Related]
